The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?

The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?

© 2015 Elsevier Masson SAS. Aims: The metabolic syndrome (MetS) is a risk factor for cancer. However, it is not known if the MetS confers a greater cancer risk than the sum of its individual components, which components drive the association, or if the MetS predicts future cancer risk. Materials and...

Full description

Bibliographic Details
Main Authors: Harding, J., Sooriyakumaran, M., Anstey, K., Adams, R., Balkau, B., Briffa, T., Davis, T., Davis, W., Dobson, A., Giles, G., Grant, J., Knuiman, M., Luszcz, M., Mitchell, P., Pasco, J., Reid, Christopher, Simmons, D., Simons, L., Tonkin, A., Woodward, M., Shaw, J., Magliano, D.
Format: Journal Article
Published: Elsevier Masson SAS 2015
Online Access:http://hdl.handle.net/20.500.11937/27405

Similar Items

Similar Items